STOCK TITAN

IAC Inc. Form 4 Filings

IAC NASDAQ

Every Form 4 that IAC Inc. (IAC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow IAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IAC filings page.

Rhea-AI Summary

People Inc director Clinton Chelsea reported receiving 135 share units of common stock valued at $46.16 per unit. The award was accrued under the Non-Employee Director Deferred Compensation Plan and is classified as a grant or other acquisition, not an open-market purchase. Following this award, Chelsea directly holds 93,336 common shares and units in total.

Rhea-AI Summary

People Inc director Lourd Bryan received additional stock-based compensation. On the reported date, Bryan acquired 352 shares of Common Stock at a value of $46.16 per share through a grant classified as a non-derivative award. Following this grant, Bryan directly holds 204,250 shares. A footnote explains these represent share units accrued under the Non-Employee Director Deferred Compensation Plan, indicating this is a routine, compensation-related accrual rather than an open-market purchase or sale.

Rhea-AI Summary

People Inc director Michael D. Eisner reported an acquisition of company stock as compensation. He received a grant of 311 shares of Common Stock at $46.16 per share in a non-derivative, award-type transaction, increasing his direct holdings to 178,764 shares.

He also has 40,555 share units held indirectly through a trust, representing amounts accrued under the Non-Employee Director Deferred Compensation Plan as of the report date. The filing shows a routine compensation-related award rather than an open-market purchase or sale.

Rhea-AI Summary

People Inc director Maria Seferian reported a compensation-related equity grant. She acquired 271 share units of Common Stock at a reference price of $46.16 per share, accrued under the Non-Employee Director Deferred Compensation Plan. Following this award, she directly holds 12,134 shares of People Inc common stock.

Rhea-AI Summary

People Inc director Clinton Chelsea reported routine equity compensation activity involving restricted stock units. On June 18, 2026, 2,263 restricted stock units converted into an equal number of shares of common stock at an exercise price of $0.00 per share. After this transaction, Chelsea directly held 93,201 shares of common stock. The filing also shows 4,528 restricted stock units outstanding following the conversion, which vest in equal installments on each of June 18, 2026, June 18, 2027, and June 18, 2028, subject to continued service. No open‑market purchases or sales were reported; the transactions reflect the exercise and vesting of equity awards.

Rhea-AI Summary

Braham Tor, a director, reported a routine equity compensation event. On June 18, 2026, 2,263 restricted stock units (RSUs) converted into 2,263 shares of IAC common stock at a stated price of $0.00 per share. Following the conversion, Tor directly holds 17,263 shares of common stock and 4,528 RSUs. The remaining RSUs are scheduled to vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

Director Michael D. Eisner of People Inc reported a routine equity award vesting. On June 18, 2026, restricted stock units converted into 2,263 shares of common stock at $0.0000 per share, reflecting compensation rather than an open-market purchase.

After this exercise, he directly holds 178,453 shares of common stock and 4,528 remaining RSUs. He also indirectly holds 40,555 shares through a trust where he serves as trustee. The remaining RSUs vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

Lourd Bryan, a director of People Inc, reported routine equity compensation activity. On June 18, 2026, restricted stock units converted into 2,263 shares of People Inc common stock, increasing his directly held common shares to 203,898.

The filing also shows 4,528 restricted stock units outstanding after the transaction. According to the disclosure, these RSUs vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service, so additional shares may be delivered over that period as awards vest.

Rhea-AI Summary

Alexander Von Furstenberg, a director of People Inc, exercised restricted stock units into common shares. On June 18, 2026, RSUs covering 2,263 shares of common stock vested and were converted at a price of $0.00 per share, a routine compensation-related event rather than an open-market trade.

Following this vesting, he directly holds 113,382 shares of common stock and 4,528 RSUs. The remaining RSUs are scheduled to vest in equal installments on June 18, 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

People Inc director Maria Seferian reported a routine equity compensation event involving restricted stock units (RSUs). On June 18, 2026, 2,263 RSUs were exercised into the same number of shares of common stock, reflecting vesting of prior awards. After this transaction, she directly held 11,863 shares of common stock and 4,528 RSUs, of which the remaining RSUs are scheduled to vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

People Inc director Alan G. Spoon acquired 2,263 shares of common stock through the vesting of restricted stock units at no cash cost per share. Following this compensation-related transaction, he holds 277,411 common shares directly and 15,000 shares indirectly through a Family LLC. He also has 4,528 restricted stock units outstanding, which are scheduled to vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

People Inc director Richard F. Zannino exercised restricted stock units into common shares as part of his equity compensation. On June 18, 2026, 2,263 RSUs converted into the same number of common shares at a $0.0000 exercise price, with no open‑market purchase or sale involved.

Following the transaction, he directly holds 64,435 shares of common stock and 4,528 RSUs that continue to vest in equal installments on June 18, 2026, 2027, and 2028, subject to continued service.

Rhea-AI Summary

Director David S. Rosenblatt reported routine equity compensation activity at IAC. On June 18, 2026, he acquired 2,263 shares of IAC common stock at a price of $0.00 per share upon the vesting of previously granted restricted stock units. Following this transaction, he directly holds 97,261 shares of common stock.

Rosenblatt also holds 4,528 restricted stock units (RSUs) after the event. According to the disclosure, these RSUs vest in equal installments on June 18, 2026, 2027, and 2028, and each installment is subject to his continued service with the company.

Rhea-AI Summary

People Inc director Bonnie S. Hammer acquired 2,263 shares of common stock on June 18, 2026 through the vesting of restricted stock units. This compensation-related event came at a price of $0.00 per share and did not involve any open-market buying or selling.

After the vesting, Hammer directly holds 40,669 shares of common stock. She also retains 4,528 restricted stock units, which are scheduled to vest in equal installments on June 18 of 2026, 2027, and 2028, subject to continued service with the company.

Rhea-AI Summary

IAC Inc. senior vice president and chief accounting officer Michael H. Schwerdtman reported an open-market sale of 6,878 shares of common stock on May 12, 2026. The weighted average sale price was $40.5352 per share, with individual trades between $40.50 and $40.62. After this transaction, he directly holds 28,743 IAC shares.

Rhea-AI Summary

EISNER MICHAEL D reported acquisition or exercise transactions in this Form 4 filing.

IAC Inc. director Michael D. Eisner received a grant of 359 share units of common stock on March 31, 2026, recorded at $40.03 per unit. The filing notes these represent share units accrued under the Non-Employee Director Deferred Compensation Plan.

Following this award, Eisner directly holds 172,505 share units. The filing also shows an indirect holding of 40,555 share units through a trust of which he is trustee, including 5,156 share units accrued under the same deferred compensation plan.

Rhea-AI Summary

IAC Inc. director Bryan Lourd reported an acquisition of 406 shares of common stock on a grant or award basis at an indicated value of $40.03 per share. Following this compensation-related award, his directly held position increased to 197,950 shares.

The filing notes that these holdings include 151,777 share units accrued under IAC’s Non-Employee Director Deferred Compensation Plan as of the report date, highlighting that a substantial portion of his interest is in deferred share units rather than only current stock.

Rhea-AI Summary

Clinton Chelsea reported acquisition or exercise transactions in this Form 4 filing.

IAC Inc. director Chelsea Clinton reported receiving a grant of 156 shares of common stock as a non-employee director award, at a reference price of $40.03 per share. Following this grant, she directly holds 87,253 shares, including 35,415 share units accrued under the Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

Seferian Maria reported acquisition or exercise transactions in this Form 4 filing.

IAC Inc. director Maria Seferian reported receiving a grant of 312 share units of common stock on March 31, 2026 at a reference price of $40.03 per share. These units were accrued under the Non-Employee Director Deferred Compensation Plan. Following this award, her directly held common stock and share units total 7,524.

Rhea-AI Summary

IAC Inc. senior vice president and chief accounting officer Michael H. Schwerdtman reported equity award activity tied to restricted stock units. On February 28, 2026, 11,262 restricted stock units vested and were converted into an equal number of shares of common stock at no cost. To cover taxes due on this vesting, 4,384 shares of common stock were withheld at a price of $38.32 per share. After these transactions, he directly owned 35,621 shares of common stock and 11,262 restricted stock units. The remaining restricted stock units vest in two equal installments on February 28, 2026 and 2027, subject to continued service, and the unvested units have been adjusted to reflect IAC’s spin-off of its ownership in Angi Inc. via a special dividend.

Rhea-AI Summary

IAC Inc. vice chairman Victor Kaufman reported routine equity compensation activity. On February 9, 2026, he received 6,845 restricted stock units, which are scheduled to vest in equal installments on February 9 of 2027, 2028, and 2029, subject to continued service.

On February 10, 2026, 2,445 restricted stock units vested and converted into common shares at $0 per share, and 1,007 of those shares were withheld at $36.47 per share to cover taxes. Following these transactions, Kaufman directly held 22,483 IAC common shares, 4,890 restricted stock units, and 68,284 additional shares were held indirectly through a trust for his spouse.

Rhea-AI Summary

IAC Inc. executive vice president and chief legal officer Kendall Handler reported routine equity compensation activity. On February 6 and 8, 2026, restricted stock units converted into IAC common stock, with portions of the resulting shares withheld at $35.65 per share to cover taxes.

The filing also shows a new award of 123,220 restricted stock units on February 9, 2026, which vest in equal installments on each of February 9, 2027, 2028, and 2029, subject to continued service. Footnotes explain earlier RSU grants with multi-year vesting schedules and note that outstanding unvested RSUs were adjusted after IAC’s March 31, 2025 spin-off of Angi Inc.

Rhea-AI Summary

IAC Inc. executive Christopher Halpin, EVP, CFO & COO, reported multiple equity compensation events involving common stock and restricted stock units. On February 6 and 8, 2026, restricted stock units vested and converted into IAC common shares, with portions of those shares withheld to cover tax obligations at a price of $35.65 per share.

The filing also shows new equity awards. On February 9, 2026, Halpin received 219,058 restricted stock units, which will convert into the same number of common shares if they vest. Other RSU positions vest over time on specified future anniversaries, conditioned on continued service. Unvested RSU amounts have been adjusted to reflect IAC’s completed spin-off of Angi Inc. through a special dividend in March 2025.

Rhea-AI Summary

IAC Inc. director Maria Seferian reported the vesting of 2,075 restricted stock units into an equal number of shares of IAC common stock on December 12, 2025, at a stated price of $0 per share. Following this transaction, she directly beneficially owned 6,892 shares of common stock and 2,074 restricted stock units. The restricted stock units were granted on December 12, 2023 and vest in three equal annual installments, subject to continued service. IAC previously completed the spin-off of its ownership in Angi Inc. on March 31, 2025 via a special dividend, and the unvested restricted stock units reported have been adjusted to reflect that spin-off.

Rhea-AI Summary

IAC Inc. insider update: On November 5, 2025, Chairman and Senior Executive Barry Diller acquired 438,757 shares of IAC common stock upon the vesting of restricted stock units. In connection with the vesting, 240,968 shares were withheld at $33.01 to satisfy tax obligations.

Following these transactions, Diller beneficially owns 665,234 shares directly and 136,711 shares indirectly through family trusts. The related RSU award of 438,757 units vested in full on November 5, 2025, with zero RSUs remaining after settlement.

Rhea-AI Summary

Maria Seferian, an IAC director, reported acquiring 367 shares of IAC common stock on 09/30/2025 at a price of $34.07 per share. After the purchase she beneficially owns 4,817 shares in total, consisting of 3,785 shares held directly and 1,032 share units accrued under the Non-Employee Director Deferred Compensation Plan. The filing notes the Deferred Shares were adjusted to reflect the Angi spin-off completed on 03/31/2025, when IAC distributed its Angi shares as a special dividend. The report was signed by an attorney-in-fact on behalf of Ms. Seferian on 10/02/2025.

Rhea-AI Summary

Chelsea Clinton, a director of IAC Inc. (IAC), reported an acquisition of 183 shares of IAC common stock on 09/30/2025 at a price of $34.07 per share. After the transaction she beneficially owned 86,937 shares, consisting of 51,838 shares held directly and 35,099 deferred share units under IACs Non-Employee Director Deferred Compensation Plan.

The filing notes the 35,099 deferred share units were adjusted to reflect the Angi spin completed by IAC on March 31, 2025. The Form 4 was signed on behalf of the reporting person by attorney Kyra Ayo Caros on 10/02/2025.

Rhea-AI Summary

Michael D. Eisner, a director of IAC Inc. (IAC), reported a purchase of 422 shares of IAC common stock on 09/30/2025 at a price of $34.07 per share. After the reported transaction, the filing shows Eisner beneficially owns 171,778 shares in total, which includes 167,349 shares held directly and 4,429 share units accrued under the Non-Employee Director Deferred Compensation Plan.

The Form 4 notes the 4,429 deferred share units were adjusted to reflect the Angi spin completed on March 31, 2025, when IAC distributed its Class A shares of Angi Inc. as a special dividend. The report was signed by Eisner's attorney-in-fact on 10/02/2025.

Rhea-AI Summary

Bryan Lourd, a director of IAC Inc. (IAC), reported an acquisition of 477 shares of IAC common stock on 09/30/2025 at a purchase price of $34.07 per share. The filing states these 477 shares represent share units accrued under the company’s Non-Employee Director Deferred Compensation Plan. After the reported transaction, Mr. Lourd beneficially owns 197,128 shares in total, comprised of 46,173 shares held directly and 150,955 deferred share units. The Deferred Shares figure was adjusted to reflect the Angi spin-off completed on 03/31/2025. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Summary

David S. Rosenblatt, a director of IAC Inc. (IAC), filed an amended Form 4 disclosing a disposition of 90,056 shares of IAC common stock reported with a transaction date of 06/23/2025. The filing clarifies that his post-transaction beneficial ownership calculation includes 58,506 shares held directly (personally or through a trust) and 31,550 deferred share units accrued under the Non-Employee Director Deferred Compensation Plan. The amendment notes an adjustment to the Deferred Shares following IAC’s Angi spin-off on 03/31/2025. The Form 4/A is signed by an attorney-in-fact for Mr. Rosenblatt on 10/02/2025.

Rhea-AI Summary

Alexander von Furstenberg, a director of IAC Inc. (IAC), filed an amended Form 4 reporting a disposition of 106,177 shares of IAC common stock with a transaction date of 06/23/2025. The amendment was filed on 06/25/2025 and the Form 4/A was signed by an attorney-in-fact on 10/02/2025. The filing explains that the reporting person holds 85,034 shares directly (including trust holdings) and 21,143 share units accrued under the Non-Employee Director Deferred Compensation Plan (the "Deferred Shares"). The Deferred Shares figure was adjusted following IAC’s Angi spin-off on 03/31/2025, which distributed Angi Class A shares to IAC shareholders by special dividend.